ResMed Total Liabilities 2010-2024 | RMD
ResMed total liabilities from 2010 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
- ResMed total liabilities for the quarter ending December 31, 2024 were $1.888B, a 22.07% decline year-over-year.
- ResMed total liabilities for 2024 were $2.008B, a 23.4% decline from 2023.
- ResMed total liabilities for 2023 were $2.622B, a 51.1% increase from 2022.
- ResMed total liabilities for 2022 were $1.735B, a 5.83% decline from 2021.
| ResMed Annual Total Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $2,008 |
| 2023 | $2,622 |
| 2022 | $1,735 |
| 2021 | $1,842 |
| 2020 | $2,090 |
| 2019 | $2,035 |
| 2018 | $1,005 |
| 2017 | $1,508 |
| 2016 | $1,562 |
| 2015 | $594 |
| 2014 | $603 |
| 2013 | $600 |
| 2012 | $530 |
| 2011 | $338 |
| 2010 | $339 |
| 2009 | $393 |
| ResMed Quarterly Total Liabilities (Millions of US $) |
|
|---|---|
| 2024-12-31 | $1,888 |
| 2024-09-30 | $2,027 |
| 2024-06-30 | $2,008 |
| 2024-03-31 | $2,185 |
| 2023-12-31 | $2,423 |
| 2023-09-30 | $2,490 |
| 2023-06-30 | $2,622 |
| 2023-03-31 | $2,781 |
| 2022-12-31 | $2,938 |
| 2022-09-30 | $1,745 |
| 2022-06-30 | $1,735 |
| 2022-03-31 | $1,626 |
| 2021-12-31 | $1,589 |
| 2021-09-30 | $1,703 |
| 2021-06-30 | $1,842 |
| 2021-03-31 | $1,876 |
| 2020-12-31 | $1,708 |
| 2020-09-30 | $1,942 |
| 2020-06-30 | $2,090 |
| 2020-03-31 | $2,254 |
| 2019-12-31 | $2,096 |
| 2019-09-30 | $2,037 |
| 2019-06-30 | $2,035 |
| 2019-03-31 | $2,077 |
| 2018-12-31 | $1,904 |
| 2018-09-30 | $1,167 |
| 2018-06-30 | $1,005 |
| 2018-03-31 | $1,467 |
| 2017-12-31 | $1,544 |
| 2017-09-30 | $1,440 |
| 2017-06-30 | $1,508 |
| 2017-03-31 | $1,568 |
| 2016-12-31 | $1,612 |
| 2016-09-30 | $1,550 |
| 2016-06-30 | $1,562 |
| 2016-03-31 | $771 |
| 2015-12-31 | $715 |
| 2015-09-30 | $794 |
| 2015-06-30 | $594 |
| 2015-03-31 | $742 |
| 2014-12-31 | $738 |
| 2014-09-30 | $656 |
| 2014-06-30 | $603 |
| 2014-03-31 | $674 |
| 2013-12-31 | $707 |
| 2013-09-30 | $642 |
| 2013-06-30 | $600 |
| 2013-03-31 | $607 |
| 2012-12-31 | $579 |
| 2012-09-30 | $546 |
| 2012-06-30 | $530 |
| 2012-03-31 | $520 |
| 2011-12-31 | $480 |
| 2011-09-30 | $386 |
| 2011-06-30 | $338 |
| 2011-03-31 | $299 |
| 2010-12-31 | $273 |
| 2010-09-30 | $315 |
| 2010-06-30 | $339 |
| 2010-03-31 | $381 |
| 2009-12-31 | $364 |
| 2009-09-30 | $417 |
| 2009-06-30 | $393 |
| 2009-03-31 | $353 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $31.269B | $4.685B |
| ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. The company currently has two operating segments, which are the Sleep and Respiratory Care segment and the Software-as-a-Service segment. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $227.162B | 27.40 |
| Boston Scientific (BSX) | United States | $140.689B | 37.90 |
| Stryker (SYK) | United States | $132.255B | 28.42 |
| EssilorLuxottica (ESLOY) | France | $128.431B | 0.00 |
| Medtronic (MDT) | Ireland | $105.938B | 15.47 |
| Lonza Group Ag (LZAGY) | Switzerland | $47.424B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.151B | 26.20 |
| Agilent Technologies (A) | United States | $29.217B | 19.30 |
| GE HealthCare Technologies (GEHC) | United States | $28.556B | 13.89 |
| Terumo (TRUMY) | Japan | $28.160B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $22.192B | 15.85 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.373B | 12.24 |
| Insulet (PODD) | United States | $17.332B | 74.11 |
| Baxter (BAX) | United States | $14.818B | 10.66 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.356B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $7.609B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.938B | 17.06 |
| Bio-Rad Laboratories (BIO) | United States | $6.672B | 23.10 |
| Demant (WILYY) | Denmark | $6.644B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.977B | 18.98 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Perrigo (PRGO) | Ireland | $3.455B | 9.89 |
| ICU Medical (ICUI) | United States | $3.400B | 29.07 |
| Haemonetics (HAE) | United States | $2.872B | 13.52 |
| Envista Holdings (NVST) | United States | $2.614B | 20.80 |
| GN Store Nord (GNNDY) | Denmark | $2.188B | 14.75 |
| LeMaitre Vascular (LMAT) | United States | $1.946B | 44.47 |
| QuidelOrtho (QDEL) | United States | $1.698B | 14.22 |
| AtriCure (ATRC) | United States | $1.565B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.214B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.189B | 18.67 |
| AdaptHealth (AHCO) | United States | $1.051B | 10.12 |
| BioLife Solutions (BLFS) | United States | $1.041B | 0.00 |
| InMode (INMD) | Israel | $1.038B | 8.67 |
| Neogen (NEOG) | United States | $0.953B | 12.19 |
| Phibro Animal Health (PAHC) | United States | $0.700B | 10.74 |
| Evolus (EOLS) | United States | $0.686B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.649B | 0.00 |
| Valneva SE (VALN) | France | $0.552B | 0.00 |
| Owens & Minor (OMI) | United States | $0.535B | 4.56 |
| CeriBell (CBLL) | United States | $0.532B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.514B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.453B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.450B | 0.00 |
| Surmodics (SRDX) | United States | $0.394B | 0.00 |
| Omeros (OMER) | United States | $0.394B | 0.00 |
| SNDL (SNDL) | Canada | $0.368B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.329B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.328B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.302B | 13.07 |
| Viemed Healthcare (VMD) | United States | $0.262B | 23.68 |
| Sanara MedTech (SMTI) | United States | $0.262B | 0.00 |
| ZimVie (ZIMV) | United States | $0.261B | 15.65 |
| Sanuwave Health (SNWV) | United States | $0.256B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.251B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.250B | 44.40 |
| Cerus (CERS) | United States | $0.242B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.224B | 0.00 |
| Quanterix (QTRX) | United States | $0.200B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.189B | 0.00 |
| High Tide (HITI) | Canada | $0.187B | 0.00 |
| Biote (BTMD) | United States | $0.181B | 4.12 |
| TriSalus Life Sciences (TLSI) | United States | $0.175B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.172B | 13.24 |
| Brainsway (BWAY) | Israel | $0.155B | 48.47 |
| Jin Medical (ZJYL) | China | $0.147B | 0.00 |
| Organigram Global (OGI) | Canada | $0.135B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.123B | 15.42 |
| Agape ATP (ATPC) | $0.094B | 0.00 | |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.086B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.083B | 0.00 |
| Exagen (XGN) | United States | $0.080B | 0.00 |
| MacroGenics (MGNX) | United States | $0.079B | 0.00 |
| Veru (VERU) | United States | $0.078B | 0.00 |
| Fonar (FONR) | United States | $0.076B | 10.65 |
| Zynex (ZYXI) | United States | $0.066B | 24.22 |
| United Health Products (UEEC) | United States | $0.065B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.064B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.063B | 0.00 |
| InterCure (INCR) | Israel | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.049B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 11.61 |
| Apyx Medical (APYX) | United States | $0.037B | 0.00 |
| Modular Medical (MODD) | United States | $0.036B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.035B | 51.50 |
| Safety Shot (SHOT) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.018B | 0.00 | |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.011B | 0.00 |
| Flora Growth (FLGC) | United States | $0.010B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.003B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.001B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |